Hims Inc. – Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

The company will offer access to GalleriĀ®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer SAN FRANCISCO–(BUSINESS WIRE)– Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by GalleriĀ®, a simple cancer … Read more